TS
Tukaram Sampat Bhondave
About Tukaram Sampat Bhondave
Data last updated:
Tukaram Sampat Bhondave has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Inducare Pharmaceuticals And Research Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Inducare Pharmaceuticals And Research Foundation at ₹7.33 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 03 Sep 2019 | 2019 | ₹7.33 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Tukaram Sampat Bhondave
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Tukaram Sampat Bhondave
Tukaram Sampat Bhondave has 7 years in corporate governance. Holds Director role. Currently with 1 company, including Inducare Pharmaceuticals And Research Foundation. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Inducare Pharmaceuticals And Research Foundation at ₹7.33 Cr (FY 2025).
Tukaram Sampat Bhondave is associated with 1 company as Director, including Inducare Pharmaceuticals And Research Foundation (₹7.33 Cr).
Tukaram Sampat Bhondave has expertise in General Business.
Tukaram Sampat Bhondave has 7 years in corporate governance.
By reported revenue, the largest current company of Tukaram Sampat Bhondave is Inducare Pharmaceuticals And Research Foundation, with revenue of ₹7.33 Cr (FY 2025).
Tukaram Sampat Bhondave currently holds positions at 1 company: Inducare Pharmaceuticals And Research Foundation (₹7.33 Cr).